Patient Activation Program for Low Anterior Resection Syndrome
Trial Summary
What is the purpose of this trial?
After undergoing restorative proctectomy for rectal cancer, many patients are left with significant bowel dysfunction, known as Low Anterior Resection Syndrome (LARS). Increased LARS severity correlates with worse perceived global health status and quality of life (QoL). Among patients undergoing rectal resection with a permanent ostomy, there is evidence that supportive and educational interventions improve QoL, ostomy proficiency, self-efficacy and knowledge. However, evidence regarding the impact of such interventions in patients who undergo restorative proctectomy is lacking, despite the latter operation being far more frequently performed. The overall goal of this study is to evaluate the extent to which a LARS Patient-Centered Program impacts on patient-reported outcome measures (PROMs) after restorative proctectomy for rectal cancer. This is a randomized-controlled muticenter trial that will include patients who have undergone restorative proctectomy for neoplastic disease (benign or malignant) located in the rectum (0-15cm from the anal verge) with a diverting ostomy and who are scheduled for ostomy closure.
Research Team
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Patient Activation Booklet and nursing support (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jewish General Hospital
Lead Sponsor
University of Manitoba
Collaborator
Providence Healthcare
Collaborator
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborator
Centre Hospitalier du Quebec
Collaborator